Jeffrey Bluestone - 26 Nov 2024 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Director
Signature
/s/ Amy Kim by Power of Attorney for Jeffrey A. Bluestone
Issuer symbol
GILD
Transactions as of
26 Nov 2024
Net transactions value
-$7,914
Form type
4
Filing time
27 Nov 2024, 18:14:41 UTC
Previous filing
09 May 2024
Next filing
08 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise $359,618 +5,879 +103% $61.17 11,587 26 Nov 2024 Direct
transaction GILD Common Stock Options Exercise $252,823 +4,121 +36% $61.35 15,708 26 Nov 2024 Direct
transaction GILD Common Stock Sale $620,356 -6,788 -43% $91.39 8,920 26 Nov 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Non-qualified Stock Option (Right to Buy) Options Exercise $0 -5,879 -100% $0.000000 0 26 Nov 2024 Common Stock 5,879 $61.17 Direct F2
transaction GILD Non-qualified Stock Option (Right to Buy) Options Exercise $0 -4,121 -26% $0.000000 11,730 26 Nov 2024 Common Stock 4,121 $61.35 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale prices reported for the transactions reported here range from $91.3901 to $91.3910. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F2 25% of the shares subject to the option vest on each three-month anniversary measured from December 8, 2020 such that 100% of the shares subject to the option will be fully vested and exercisable on December 8, 2021.
F3 100% of the shares subject to the stock option vested immediately upon the grant date of May 5, 2022.